Corrigendum: A New Prognostic Risk Score: Based on the Analysis of Autophagy-Related Genes and Renal Cell Carcinoma

Minxin He,Mingrui Li,Yawen Guan,Ziyan Wan,Jie Tian,Fangshi Xu,Haibin Zhou,Mengchun Gao,Hang Bi,Tie Chong

DOI: https://doi.org/10.3389/fgene.2022.904512

IF: 3.7

2022-01-01

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2021.820154.].

What problem does this paper attempt to address?

Corrigendum: Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma

Dongshan Chen,Chen Zhang,Yuanwei Zang,Wei Wang,Jiandong Zhang

DOI: https://doi.org/10.3389/fgene.2024.1440802

IF: 3.7

2024-06-27

Frontiers in Genetics

Abstract:This article is a correction to: Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma

genetics & heredity
Corrigendum: Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer

Yang He,Yongxin Wu,Zhe Liu,Boping Li,Ning Jiang,Peng Xu,Abai Xu

DOI: https://doi.org/10.3389/fgene.2022.880633

IF: 3.7

2022-05-17

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2021.694777.].

genetics & heredity
Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Si Liu,Honglan Zhou,Gang Wang,Xin Lian

DOI: https://doi.org/10.3389/fcell.2023.1216783

IF: 5.5

2023-06-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.709490.].

cell biology,developmental biology
Correction: Prognostic and Clinicopathological Value of P53 Expression in Renal Cell Carcinoma: a Meta-Analysis

Zhun Wang,Shuanghe Peng,Ning Jiang,Aixiang Wang,Shuguang Liu,Hui Xie,Linpei Guo,Qiliang Cai,Yuanjie Niu

DOI: https://doi.org/10.18632/oncotarget.26394

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.21971.].
Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

TingAn Wang,HuaGe Zhong,YuZhou Qin,WeiYuan Wei,Zhao Li,MingWei Huang,XiaoLing Luo

DOI: https://doi.org/10.1155/2021/3179693

2021-02-09

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/3575038.].

biotechnology & applied microbiology,medicine, research & experimental
Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer

Sheng Liu,Wenting Tang,Jing Cao,Mei Shang,Sun Hengchang,Jiao Gong,Bo Hu

DOI: https://doi.org/10.3389/fgene.2024.1357409

IF: 3.7

2024-01-26

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.904114.].

genetics & heredity
Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Yaxin Chen,Lei Xia,Yuxuan Peng,Gang Wang,Liyun Bi,Xue Xiao,Cui Li,Weimin Li

DOI: https://doi.org/10.3389/fonc.2023.1309950

IF: 4.7

2023-11-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.947808.].

oncology
Corrigendum: Development and validation of a prognostic nomogram based on DNA methylation-driven genes for patients with ovarian cancer

Min Zhou,Shasha Hong,Bingshu Li,Cheng Liu,Ming Hu,Jie Min,Jianming Tang,Li Hong

DOI: https://doi.org/10.3389/fgene.2022.951409

IF: 3.7

2022-08-15

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2021.675197.].

genetics & heredity
Corrigendum: A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer

Peijie Chen,Yuting Gao,Si Ouyang,Li Wei,Min Zhou,Hua You,Yao Wang

DOI: https://doi.org/10.3389/fphar.2021.723153

IF: 5.6

2021-08-25

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.585255.].

pharmacology & pharmacy
Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma

Tingting Deng,Yang Liu,Jialang Zhuang,Yizhe Tang,Qin Huo

DOI: https://doi.org/10.3389/fonc.2022.979968

IF: 4.7

2022-08-22

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.632042.].

oncology
Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Feng Shi,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].
Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Fangling Cheng,Po Zhang,Qungen Xiao,Youwei Li,Minhai Dong,Heping Wang,Dong Kuang,Yue He,Qiuhong Duan,Feng Mao,Baofeng Wang,Dongsheng Guo

DOI: https://doi.org/10.3389/fonc.2020.591112

2020-09-25

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00447.].
Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Yicong Yao,Yi Wang,Denglong Wu,Baoying Hu

DOI: https://doi.org/10.3389/fonc.2021.731942

IF: 4.7

2021-07-21

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.666418.].

oncology
Correction to: ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma

Weipu Mao,Keyi Wang,Bin Xu,Hui Zhang,Si Sun,Qiang Hu,Lei Zhang,Chunhui Liu,Shuqiu Chen,Jianping Wu,Ming Chen,Wei Li,Bo Peng

DOI: https://doi.org/10.1186/s12943-021-01459-8

IF: 37.3

2021-12-01

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,biochemistry & molecular biology
Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Xin Tian,Lina Wu,Min Jiang,Zhenyong Zhang,Rong Wu,Jianing Miao,Caigang Liu,Song Gao

DOI: https://doi.org/10.3389/fonc.2022.793448

IF: 4.7

2022-04-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.641399.].

oncology
Corrigendum: Molecular Portrait of GIST Associated With Clinicopathological Features: A Retrospective Study With Molecular Analysis by a Custom 9-Gene Targeted Next-Generation Sequencing Panel

Haoran Qian,Na Yan,Xiaotong Hu,Junchang Jiang,Zhengzheng Cao,Dan Shen

DOI: https://doi.org/10.3389/fgene.2022.945357

IF: 3.7

2022-06-28

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.864499.].

genetics & heredity
Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Wan-Xin Peng,Fei Liu,Jia-Hong Jiang,Hang Yuan,Ziqiang Zhang,Liu Yang,Yin-Yuan Mo

DOI: https://doi.org/10.1016/j.gendis.2024.101352

2024-06-15

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.014.].
Erratum: [Corrigendum] miR‑216a‑5p acts as an oncogene in renal cell carcinoma.

Peijie Chen,Jing Quan,Lu Jin,Canbin Lin,Weijie Xu,Jinling Xu,Xin Guan,Zebo Chen,Liangchao Ni,Shangqi Yang,Yun Chen,Yongqing Lai

DOI: https://doi.org/10.3892/etm.2024.12443

IF: 2.7

2024-01-01

Experimental and Therapeutic Medicine

Abstract:[This corrects the article DOI: 10.3892/etm.2018.5881.].
[Corrigendum] miR‐216a‐5p acts as an oncogene in renal cell carcinoma

Peijie Chen,Jing Quan,Lu Jin,Canbin Lin,Weijie Xu,Jinling Xu,Xin Guan,Zebo Chen,Liangchao Ni,Shangqi Yang,Yun Chen,Yongqing Lai

DOI: https://doi.org/10.3892/etm.2024.12443

IF: 2.7

2024-02-21

Experimental and Therapeutic Medicine

Abstract:[This corrects the article DOI: 10.3892/etm.2018.5881.].

medicine, research & experimental
Corrigendum: EXOSC5 As a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer Via Activating the ERK and AKT Pathways

Hongda Pan,Jingxin Pan,Shibo Song,Lei Ji,Hong Lv,Zhangru Yang

DOI: https://doi.org/10.3389/fonc.2021.670041

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00643.].

Corrigendum: A New Prognostic Risk Score: Based on the Analysis of Autophagy-Related Genes and Renal Cell Carcinoma

Corrigendum: Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma

Corrigendum: Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer

Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Correction: Prognostic and Clinicopathological Value of P53 Expression in Renal Cell Carcinoma: a Meta-Analysis

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer

Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Corrigendum: Development and validation of a prognostic nomogram based on DNA methylation-driven genes for patients with ovarian cancer

Corrigendum: A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer

Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes &amp; Diseases 9(2022) 443–455]

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Correction to: ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma

Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Corrigendum: Molecular Portrait of GIST Associated With Clinicopathological Features: A Retrospective Study With Molecular Analysis by a Custom 9-Gene Targeted Next-Generation Sequencing Panel

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Erratum: [Corrigendum] miR‑216a‑5p acts as an oncogene in renal cell carcinoma.

[Corrigendum] miR‐216a‐5p acts as an oncogene in renal cell carcinoma

Corrigendum: EXOSC5 As a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer Via Activating the ERK and AKT Pathways

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]